GCN2 and perk kinase inhibitors and methods of use thereof
Grant
US12577249B2
Kind: B2
Mar 17, 2026
Assignee
Deciphera Pharmaceuticals, LLC
Inventors
Yu Mi Ahn, Gada Al-Ani, Daniel L. Flynn, Salim Javed, Patrick Kearney, Bertrand LeBourdonnec, Kristen Stoltz, Jeffery Zwicker
Abstract
Described herein are compounds that are inhibitors of GCN2 kinase or PERK kinase, and methods of treating diseases, including diseases associated with GCN2 kinase or PERK kinase, with said compounds.
CPC Classifications
C07D 487/04
A61P 35/00
A61K 45/06
Filing Date
2022-12-02
Application No.
18073886
Claims
28